Medical Doctor Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

Leigh Casadaban

Vascular & Interventional Radiology Aurora, CO Medical Doctor

NPI 1962883470 CMS profile 1361227

12605 E 16Th Ave, Aurora, CO 80045

Open in the dashboard

General payments

$30,984

167 records reported · program years 2020–2025

Research payments

$0

Paid to them · None reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Leigh Casadaban of Aurora, CO is reported in the CMS Open Payments database as having received $30,984 across 167 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 88th percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $5,178 34
2024 General $6,941 43
2023 General $15,259 44
2022 General $2,824 29
2021 General $685 11
2020 General $98 6

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Leigh Casadaban
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Leigh Casadaban were reported at $5,178. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Leigh Casadaban Vascular & Interventional Radiology median Middle half National median
2019 $0 $422 $125–$1,555 $163
2020 $98 $200 $68–$652 $114
2021 $685 $280 $99–$866 $132
2022 $2,824 $433 $137–$1,497 $149
2023 $15,259 $506 $152–$2,019 $160
2024 $6,941 $556 $175–$1,930 $164
2025 $5,178 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. Boston Scientific Corporation $23,031 57 payments
  2. Inari Medical, Inc. $2,837 29 payments
  3. Terumo Medical Corporation $705 7 payments
  4. Ethicon US, LLC $698 14 payments
  5. AngioDynamics, Inc. $657 18 payments
  6. Medtronic, Inc. $609 10 payments
  7. Penumbra, Inc. $603 10 payments
  8. Surefire Medical, Inc. $572 7 payments
  9. Asahi Intecc USA, Inc. $275 3 payments
  10. Baxter Healthcare $238 2 payments
  11. Other $759 10 payments

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $16,600 8 payments
  2. Food and Beverage $12,117 153 payments
  3. Travel and Lodging $2,267 6 payments
Products named General payments · program years 2020–2025
  1. FLOWTRIEVER CATHETER, S $2,996 32 payments
  2. CT THROMBECTOMY SYSTEM KIT $2,742 30 payments
  3. General - Embolics $2,558 3 payments
  4. TheraSphere Y90 Glass Microspheres 10 GBq $2,229 9 payments
  5. Azur CX Detachable $691 6 payments
  6. TRINAV INFUSION SYSTEM $572 7 payments
  7. Certus 140 $569 12 payments
  8. TheraSphere Administration Set $484 3 payments
  9. Indigo System $456 9 payments
  10. EMBOLD Fibered $401 7 payments
  11. Other $3,868 62 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 86 billing codes

Paid by Medicare

$37,564

Medicare's payments for the services billed

Medicare patients

153

Average age 70

Services billed

523

73 women, 80 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 54%
Chronic kidney disease 46%
Ischemic heart disease 38%
Diabetes 33%
Depression 33%
Cancer 31%
Heart failure 29%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

167 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular & Interventional Radiology in Colorado

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record